USD 0.03
(6.67%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | -14.36 Million USD | 47.47% |
2022 | -27.33 Million USD | 75.62% |
2021 | -112.12 Million USD | -22.76% |
2020 | -91.33 Million USD | -25.86% |
2019 | -72.56 Million USD | -92.23% |
2018 | -37.75 Million USD | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q2 | 301 Thousand USD | 152.35% |
2024 Q1 | -575 Thousand USD | -101.61% |
2023 Q1 | -17.3 Million USD | -202.87% |
2023 FY | -14.36 Million USD | 47.47% |
2023 Q3 | -12.93 Million USD | 24.66% |
2023 Q2 | -17.17 Million USD | 0.79% |
2023 Q4 | 35.68 Million USD | 375.87% |
2022 Q3 | -20.46 Million USD | -237.06% |
2022 Q2 | 14.92 Million USD | 138.64% |
2022 Q1 | -38.63 Million USD | -29.2% |
2022 FY | -27.33 Million USD | 75.62% |
2022 Q4 | 16.82 Million USD | 182.22% |
2021 FY | -112.12 Million USD | -22.76% |
2021 Q3 | -27.08 Million USD | 0.77% |
2021 Q4 | -29.9 Million USD | -10.38% |
2021 Q2 | -27.3 Million USD | 1.91% |
2021 Q1 | -27.83 Million USD | 0.62% |
2020 Q3 | -26.26 Million USD | -34.92% |
2020 Q2 | -19.46 Million USD | -10.6% |
2020 Q1 | -17.6 Million USD | 0.4% |
2020 FY | -91.33 Million USD | -25.86% |
2020 Q4 | -28 Million USD | -6.64% |
2019 Q1 | -9.85 Million USD | 0.0% |
2019 FY | -72.56 Million USD | -92.23% |
2019 Q4 | -17.67 Million USD | 43.3% |
2019 Q3 | -31.16 Million USD | -124.61% |
2019 Q2 | -13.87 Million USD | -40.73% |
2018 FY | -37.75 Million USD | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
Biotricity, Inc. | -8.82 Million USD | -62.671% |
Cell MedX Corp. | -313.43 Thousand USD | -4481.884% |
Dynatronics Corporation | -2.27 Million USD | -531.795% |
Nemaura Medical Inc. | -9.59 Million USD | -49.668% |
PetVivo Holdings, Inc. | -10.62 Million USD | -35.209% |
RetinalGenix Technologies Inc. | -2.08 Million USD | -588.101% |
Sonendo, Inc. | -57.74 Million USD | 75.129% |
Telesis Bio, Inc. | -35.15 Million USD | 59.144% |
Talis Biomedical Corporation | -66.81 Million USD | 78.506% |
Viveve Medical, Inc. | -21.55 Million USD | 33.369% |